Study Finds Cannabis Users Have Half the Risk of Developing Type 2 Diabetes

Researchers from Iran have published a study in the journal Phytotherapy Research examining the effects of cannabis on glucose regulation and insulin secretion. The team analyzed 11 surveys and four epidemiological studies from scientific databases, all published before July 1, 2022. They found that the incidence of type 2 diabetes among people who use cannabis was “0.48 times lower than among those who were not exposed to cannabis.”

Previous studies have also linked cannabis use to a reduced incidence of type 2 diabetes, a condition in which patients produce low levels of insulin and may become resistant to this hormone.

The researchers note that further, more in-depth studies are needed, but it is already clear that cannabis compounds may play a role in regulating various bodily functions, including insulin secretion.

Numerous trials indirectly support the impact of cannabis on human metabolism. For example, it has already been proven that cannabis legalization is associated with a decrease in obesity rates, despite cannabis being a well-known appetite stimulant. Another study showed that in states where cannabis was legalized, there was a significant reduction in health insurance premiums compared to states where cannabis remained completely illegal.

Our other channels

Our friends and partners